Huang Y R
Cancer Institute, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1988 Nov;10(6):470-2.
From June 1983 to Jan. 1985, 75 patients with early stage non-Hodgkin's lymphoma were treated in our hospital. The ages ranged from 3 to 65 years. The ratio of male to female was 2.75. The intermediate and high grade malignant lymphoma comprised 89.3% of the whole group. By clinical staging, there were 23 Stage I, 44 Stage II, and 8 Stage III lesions. The primary sites were: 33 in the Waldeyer's ring, 22 in lymph nodes, 10 in the nasal cavity and 10 in the other organs. The two-year survival rate of the whole group was 69.3%. In view of the results, the prognosis was related to the staging, A or B symptoms, primary site and CR or PR after treatment, but the age was irrelevant. The results also showed that intermediate or high grade malignancy gave no significant difference in the two-year survival rate. It might be due to the fact that they were originated from the large cell type of lymphoma in the intermediate group and possessed similar malignant properties as the high grade lymphoma.
1983年6月至1985年1月，我院对75例早期非霍奇金淋巴瘤患者进行了治疗。年龄范围为3至65岁。男女比例为2.75。中、高度恶性淋巴瘤占整个组的89.3%。根据临床分期，有23例I期、44例II期和8例III期病变。原发部位为：Waldeyer环33例，淋巴结22例，鼻腔10例，其他器官10例。整个组的两年生存率为69.3%。鉴于结果，预后与分期、A或B症状、原发部位以及治疗后的CR或PR有关，但与年龄无关。结果还表明，中、高度恶性在两年生存率方面无显著差异。这可能是由于它们起源于中间组的大细胞型淋巴瘤，并且具有与高度淋巴瘤相似的恶性特性。
